Finfeed Archived Apr 01, 2021
Bod Australia (ASX: BDA) achieved record medicinal cannabis sales growth in the March quarter, filling 3789 MediCabilis™ prescriptions.
Get expert stock analysis direct in your inbox
Join OurMailing List
Discover Small CapBiotech Stocks
Join thousands of other Investors following our stock commentary for Free
